|
SELO expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.57669999999844E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.581730E-04 |
| Normal-vs-Stage2 |
1.433070E-04 |
| Normal-vs-Stage3 |
1.47539999995061E-07 |
| Normal-vs-Stage4 |
6.54639999986273E-07 |
| Stage1-vs-Stage2 |
3.503000E-01 |
| Stage1-vs-Stage3 |
2.699200E-03 |
| Stage1-vs-Stage4 |
5.476300E-03 |
| Stage2-vs-Stage3 |
1.050430E-01 |
| Stage2-vs-Stage4 |
2.631800E-02 |
| Stage3-vs-Stage4 |
4.230400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.74175999999582E-05 |
| Normal-vs-AfricanAmerican |
1.91880999999006E-05 |
| Normal-vs-Asian |
2.190000E-01 |
| Caucasian-vs-AfricanAmerican |
4.210200E-01 |
| Caucasian-vs-Asian |
7.897000E-01 |
| AfricanAmerican-vs-Asian |
9.949200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.992500E-04 |
| Normal-vs-Female |
4.57139999965328E-07 |
| Male-vs-Female |
1.641590E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.158420E-03 |
| Normal-vs-Extreme_Weight |
2.778900E-04 |
| Normal-vs-Obese |
2.82360000047888E-07 |
| Normal-vs-Extreme_Obese |
1.469710E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.885200E-01 |
| Normal_Weight-vs-Obese |
4.553000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.691200E-01 |
| Extreme_Weight-vs-Obese |
1.495590E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.429400E-01 |
| Obese-vs-Extreme_Obese |
2.921800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.614400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.62090999999975E-05 |
| Normal-vs-Age(61-80Yrs) |
4.231000E-04 |
| Normal-vs-Age(81-100Yrs) |
2.231100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.163000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.263800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.974200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.777200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.110600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.038390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.812300E-02 |
| Normal-VS-Type2 PRCC |
4.84057238736568E-14 |
| Normal-VS-KIRP CIMP |
6.60804744256893E-13 |
| Normal-VS-Unclassified PRCC |
6.03630000428623E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.63202784619898E-12 |
| Type1 PRCC-VS-KIRP CIMP |
2.5847990414718E-11 |
| Type1 PRCC-VS-Unclassified PRCC |
4.62629999997688E-06 |
| Type2 PRCC-VS-KIRP CIMP |
8.861200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.571540E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.87879999999918E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.405400E-04 |
| Normal-vs-N1 |
1.25239818515865E-11 |
| Normal-vs-N2 |
1.229030E-04 |
| N0-vs-N1 |
1.229130E-04 |
| N0-vs-N2 |
1.132400E-01 |
| N1-vs-N2 |
7.901400E-01 |
|
|
